Theravance Biopharma (TBPH): Look Ahead To 2017 - Leerink
Tweet Send to a Friend
Leerink analyst, Geoffrey Porges, reiterated his Outperform rating on shares of Theravance Biopharma (NASDAQ: TBPH) after the company reported a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE